Eli Lilly raised its full-year profit and revenue forecast on Thursday as strong appetite for its widely popular weight-loss ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.
Cipla Ltd (BOM:500087) reports an all-time high quarterly revenue, strategic biosimilar launch in the US, and revised EBITDA guidance amidst market challenges.